JACQUELINE LARREA: Open Payments
NPI 1083009328 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 35 payments from 7 companies in 2025. Trend: 2023 $1,085 · 2024 $866 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $386 |
| Madrigal Pharmaceuticals | 5 | $104 |
| Ipsen Biopharmaceuticals, Inc | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $38 |
| GENZYME CORPORATION | 2 | $34 |
| Celltrion USA Inc. | 1 | $19 |
Products named: SKYRIZI, RINVOQ, REZDIFFRA, IQIRVO, ENTYVIO, TREMFYA, DUPIXENT, VEGZELMA.
Industry payments across FL — which companies pay providers there.
